Pharmafile Logo

Accenture

Lucid Group brings creative and digital magic to the mix with the acquisition of Bluedog

Lucid Group is delighted to announce its first acquisition, welcoming colleagues from creative and digital consultancy Bluedog into its magic kingdom.Over the last twelve years, Lucid Group has become well...

Lucid Group Communications Limited

- PMLiVE

Bicycle Therapeutics to tackle AMR with government funding

Biotech to discover new class of antibacterial agents

Pharma iPad detailing doctors physicians

A genomics and digital-led NHS is possible – but investment in staff essential

Powerful technologies will lead to an “evolution of the patient-doctor relationship”

- PMLiVE

Industry concerned about ‘rushed’ Brexit withdrawal legislation

The Patents Amendment could weaken the UK’s IP framework, warns biopharma

- PMLiVE

CAR-Ts go head-to-head after NICE clears Kymriah in DLBCL

Novartis agrees pricing deal with NHS England

- PMLiVE

Nerve centre gives Novartis edge in clinical trials

Algorithms predict potential delays

- PMLiVE

Medicines will take priority over food in no-deal Brexit

The UK is more reliant on the EU for medicines than food, says Hancock

- PMLiVE

UK biotech booms in 2018, despite Brexit worries

Industry attracted a record-breaking £2.2bn in investment last year

- PMLiVE

UK unveils new antibiotic buying plan, pharma incentives

Health minister compares upfront payment model to Spotify

- PMLiVE

Crunch time as Brexit deal faces ‘meaningful vote’

Rejecting the deal would either result in a no deal or no Brexit, warns May

- PMLiVE

Time running out for ‘no-deal’ Brexit medicines laws

Needs parliament clearance before 29 March

- PMLiVE

D-day: time to make digital deliver

Chris Ross looks at why a platform-based, outcomes-focused approach could be key to demonstrating the value of digital health solutions

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links